Covishield Ready For Public Use By December, Informs SII
– Elderly Responding Well To Oxford Vaccine – In a recent update, Adar Poonawalla, CEO of Pune-based Serum Institute of India (SII) has informed that Covishield – the coronavirus vaccine, being developed by Oxford University and British firm AstraZeneca, could be ready for public use in December 2020. SII is currently conducting the phase-3 trial…